CS-010mixed
Royal Philips (Koninklijke Philips N.V.)
Portfolio transformation from conglomerate to health-technology company
- Region
- Western Europe, Global
- Country
- Netherlands, Global
- Industry
- Medical and Health Technology (Discrete Manufacturing)
- Functions
- Strategy, Corporate Development & Transformation Office, Finance & FP&A, Risk, Compliance & Internal Audit
- Topics
- Investment capital is not generating returns; M&A integration or corporate complexity is destroying value; Margins are eroding despite revenue; Regulatory complexity is overwhelming controls
- Starting situation
- Group of business units
- Period
- 2011–2021
- Last verified
- 31 October 2026
Executive summary
From 2011 to 2021 Royal Philips turned itself from a diversified electronics conglomerate into a health-technology company. It sold its television and lifestyle-entertainment businesses in 2012-2013, ran a cost and operating-model programme called Accelerate!, announced in 2014 that it would split off Lighting, listed Lighting in 2016 and sold the last shares in 2019, and agreed to sell Domestic Appliances in 2021, which its CEO said concluded the major divestments [C01, C02, C04, C06, C07, C08, C09].
Three numbers: a 2011 net loss of EUR 1,291m before the programme [C16]; about EUR 4.4bn of total value from the Domestic Appliances sale, the last major exit [C08]; and a US$1.1bn settlement of US personal-injury claims in 2024 over the Respironics recall in the retained business [C28]. The divestment figures are company-reported; the settlement is company-reported and carries no admission of fault [C28].
KB analysis — the one lesson: Philips executed its announced portfolio separation in stages and on its own terms, but completing a portfolio refocus does not reduce the operational and regulatory risk in the business kept; it concentrates the company's exposure to it.
Outcome: mixed
Documented shortfalls or reversals sit alongside documented gains. For example: an initial failure later recovered, or a strategic goal met while a major adverse event in the same programme was recorded.
Basis of the outcome
Philips carried out the separation it announced in 2014: Lighting was listed in 2016 and fully sold by 2019, and Domestic Appliances was sold in 2021, which Philips said concluded its major divestments. The remaining health-technology company then recorded a recall that the FDA said affected 15 million devices worldwide (Philips expected to remediate up to 5.6 million), a 2024 US consent decree halting new sleep-device sales, and net losses in 2022 and 2023. The KB does not assert that the portfolio strategy caused the recall.
Key figures
| Phase | Figure | Value | When | Verification |
|---|---|---|---|---|
| Before | Net result | EUR −1,291m | 2011 | company_reported |
| Before | Q4 EBITA margin | 7.5% (14.1% a year earlier) | Q4 2011 | company_reported |
| Before | Employees (FTE) | 125,241 | end 2011 | company_reported |
| During | Accelerate! savings programme | raised to EUR 1.1bn by 2014 | Sep 2012 | company_reported |
| During | Overhead savings achieved | EUR 471m cumulative | 2012 | company_reported |
| During | 2013 sales of the two future companies | HealthTech EUR 14.8bn; Lighting EUR 8.4bn | 2013 | company_reported |
| During | Lighting IPO | 25% sold at EUR 20/share; ~EUR 3bn implied value | May 2016 | press_reported |
| During | Final Signify sell-down | 13.8m shares, ~EUR 357m | Sep 2019 | company_reported |
| After | Domestic Appliances sale | ~EUR 4.4bn total value | Mar 2021 | company_reported |
| After | Group sales / employees | EUR 17.3bn / ~78,000 | 2020 | company_reported |
| After | Respironics devices in recall | 15m affected worldwide (FDA); up to 5.6m to be remediated (Philips) | 2021–2024 | official_statement |
| After | Net result | EUR −1.61bn (2022); EUR −463m (2023) | 2022–2023 | press_reported |
| After | US personal-injury settlement | US$1.1bn (EUR 982m provision) | Apr 2024 | company_reported |
- company_reported
- A company statement, press release or investor presentation that no one has independently checked.
- press_reported
- A journalist's own reporting.
- official_statement
- A government or ministerial statement. It is official, but political, and is not a finding.
Practices this case bears on
- SupportsScale risk, quality and control functions with the speed and size of the change BP-027
- SupportsRenew the leadership team quickly, choosing leaders from where the business is going BP-029
- SupportsTreat regulators and the state as design constraints from day one, with priced remedies and a fallback BP-041
- SupportsFix the core product and operation before amplifying the channel or scaling the new strategy BP-045
- SupportsSeparate businesses in stages and choose the exit structure asset by asset BP-052
- SupportsWhen a failure hits customers, tell them early, fix it completely, and compensate consistently BP-066
Sources
- S01 Philips gives update on its Accelerate! program that continues to make good progress · not stated, Philips (press release, archived on signify.com), 2012-09-11 · accessed 2026-10-31
- S02 Electronics giant Philips to split in historic move · Maude Brulard (AFP), IndustryWeek (AFP), 2014-09-23 · accessed 2026-10-31
- S03 Philips Lighting spin-off valued at over $3B · not stated, CNBC, 2016-05-27 · accessed 2026-10-31
- S04 Royal Philips sells its remaining shares in Signify for total proceeds of approximately EUR 357 million · not stated, Royal Philips, 2019-09-19 · accessed 2026-10-31
- S05 Philips to sell its Domestic Appliances business to global investment firm Hillhouse Capital · not stated, Royal Philips, 2021-03-25 · accessed 2026-10-31
- S06 Philips stops selling devices in US under FDA consent decree · Nick Paul Taylor, MedTech Dive, 2024-01-29 · accessed 2026-10-31
- S20 FDA Activities Related to Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines · not stated, U.S. Food and Drug Administration, 2024-11-20 · accessed 2026-10-31
- S21 Communiqué de presse n° 97/15: arrêts du Tribunal dans les affaires des tubes cathodiques (General Court judgments in the cathode-ray-tube cartel cases) · not stated, Court of Justice of the European Union, 2015-09-09 · accessed 2026-10-31
- S22 CJEU upholds €1.47bn fines over cathode tube cartels · not stated, Out-Law News (Pinsent Masons), 2017-09-22 · accessed 2026-10-31
- S07 Creating two leading companies (presentation on the separation) · Frans van Houten, CEO, Royal Philips, 2014-09-23 · accessed 2026-10-31
- S08 Transforming Royal Philips: Seeking Local Relevance While Leveraging Global Scale (MIT CISR Working Paper No. 394) · Martin Mocker, Jeanne W. Ross, Eric van Heck, MIT Sloan Center for Information Systems Research, 2014-02-27 · accessed 2026-10-31
- S09 Philips must speed up its operations, says new CEO · not stated, DutchNews.nl, 2011-06-01 · accessed 2026-10-31
- S10 Philips picks successor to Kleisterlee · not stated, DutchNews.nl, 2010-07-08 · accessed 2026-10-31
- S11 Fourth quarter and annual results 2011 · not stated, Royal Philips (via Mynewsdesk), 2012-01-30 · accessed 2026-10-31
- S12 Fourth quarter and annual results 2012 · not stated, Royal Philips, 2013-01 · accessed 2026-10-31
- S13 Respironics FAQs (as of 29 January 2024) · not stated, Royal Philips, 2024-01-29 · accessed 2026-10-31
- S14 Philips Respironics finalizes consent decree regarding business operations in the US with Department of Justice, FDA · not stated, Pharmaceutical Executive, 2024-04-10 · accessed 2026-10-31
- S15 Philips Lighting Unit Sale Blocked Over US Fears · not stated, IndustryWeek (AFP), 2016-01-22 · accessed 2026-10-31
- S16 Philips' First-Quarter Results 2024 · not stated, Royal Philips, 2024-04-29 · accessed 2026-10-31
- S17 Philips scraps 6,000 jobs in drive to improve profitability · not stated, CNBC, 2023-01-30 · accessed 2026-10-31
- S18 Philips' Fourth-Quarter and Annual Results 2021 · not stated, Royal Philips, 2022-01-24 · accessed 2026-10-31
- S19 Philips announces CEO succession · not stated, Royal Philips, 2022-08-16 · accessed 2026-10-31
Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026 · Last verified 31 October 2026
Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.

